|
1
|
World Health Organization. Global
tuberculosis report 2017. 2017.
|
|
2
|
Ait-Oufella H, Taleb S, Mallat Z and
Tedgui A: Recent advances on the role of cytokines in
atherosclerosis. Arterioscler Thromb Vasc Biol. 31:969–979.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ross R and Agius L: The process of
atherogenesis-cellular and molecular interaction: From experimental
animal models to humans. Diabetologia. 35 (Suppl 2):S34–S40.
1992.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gibson MS, Domingues N and Vieira OV:
Lipid and non-lipid factors affecting macrophage dysfunction and
inflammation in atherosclerosis. Front Physiol.
9(654)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Khallou-Laschet J, Varthaman A, Fornasa G,
Compain C, Gaston AT, Clement M, Dussiot M, Levillain O,
Graff-Dubois S, Nicoletti A and Caligiuri G: Macrophage plasticity
in experimental atherosclerosis. PLoS One. 5(e8852)2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chavez-Sanchez L, Espinosa-Luna JE,
Chavez-Rueda K, Legorreta-Haquet MV, Montoya-Diaz E and
Blanco-Favela F: Innate immune system cells in atherosclerosis.
Arch Med Res. 45:1–14. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Huang WC, Sala-Newby GB, Susana A, Johnson
JL and Newby AC: Classical macrophage activation up-regulates
several matrix metalloproteinases through mitogen activated protein
kinases and nuclear factor-κB. PLoS One. 7(e42507)2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bentzon JF, Otsuka F, Virmani R and Falk
E: Mechanisms of plaque formation and rupture. Circ Res.
114:1852–1866. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gronberg C, Nilsson J and Wigren M: Recent
advances on CD4+ T cells in atherosclerosis and its
implications for therapy. Eur J Pharmacol. 816:58–66.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kolls JK and Linden A: Interleukin-17
family members and inflammation. Immunity. 21:467–476.
2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tarantino G, Costantini S, Finelli C,
Capone F, Guerriero E, La Sala N, Gioia S and Castello G: Is serum
interleukin-17 associated with early atherosclerosis in obese
patients? J Transl Med. 12(214)2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
de la Paz Sanchez-Martinez M,
Blanco-Favela F, Mora-Ruiz MD, Chavez-Rueda AK, Bernabe-Garcia M
and Chavez-Sanchez L: IL-17-differentiated macrophages secrete
pro-inflammatory cytokines in response to oxidized low-density
lipoprotein. Lipids Health Dis. 16(196)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hurlimann J, Thorbecke GJ and Hochwald GM:
The liver as the site of C-reactive protein formation. J Exp Med.
123:365–378. 1966.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Khreiss T, Jozsef L, Potempa LA and Filep
JG: Conformational rearrangement in C-reactive protein is required
for proinflammatory actions on human endothelial cells.
Circulation. 109:2016–2022. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Khreiss T, Jozsef L, Potempa LA and Filep
JG: Loss of pentameric symmetry in C-reactive protein induces
interleukin-8 secretion through peroxynitrite signaling in human
neutrophils. Circ Res. 97:690–697. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ji SR, Wu Y, Zhu L, Potempa LA, Sheng FL,
Lu W and Zhao J: Cell membranes and liposomes dissociate C-reactive
protein (CRP) to form a new, biologically active structural
intermediate: mCRP(m). FASEB J. 21:284–294. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Eisenhardt SU, Thiele JR, Bannasch H,
Stark GB and Peter K: C-reactive protein: How conformational
changes influence inflammatory properties. Cell Cycle. 8:3885–3892.
2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Filep JG: Platelets affect the structure
and function of C-reactive protein. Circ Res. 105:109–111.
2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
McFadyen JD, Kiefer J, Braig D,
Loseff-Silver J, Potempa LA, Eisenhardt SU and Peter K:
Dissociation of C-reactive protein localizes and amplifies
inflammation: Evidence for a direct biological role of C-reactive
protein and its conformational changes. Front Immunol.
9(1351)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Caprio V, Badimon L, Di Napoli M, Fang WH,
Ferris GR, Guo B, Iemma RS, Liu D, Zeinolabediny Y and Slevin M:
pCRP-mCRP dissociation mechanisms as potential targets for the
development of small-molecule anti-inflammatory chemotherapeutics.
Front Immunol. 9(1089)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Singh SK, Suresh MV, Voleti B and Agrawal
A: The connection between C-reactive protein and atherosclerosis.
Ann Med. 40:110–120. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tabuchi M, Inoue K, Usui-Kataoka H,
Kobayashi K, Teramoto M, Takasugi K, Shikata K, Yamamura M, Ando K,
Nishida K, et al: The association of C-reactive protein with an
oxidative metabolite of LDL and its implication in atherosclerosis.
J Lipid Res. 48:768–781. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang JM and An J: Cytokines,
inflammation, and pain. Int Anesthesiol Clin. 45:27–37.
2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol. 111:A3.B.1–A3.B.3.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Taylor KE and van den Berg CW: Structural
and functional comparison of native pentameric, denatured monomeric
and biotinylated C-reactive protein. Immunology. 120:404–411.
2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Krayem I, Bazzi S and Karam M: The
combination of CRP isoforms with oxLDL decreases TNF-α and IL-6
release by U937-derived macrophages. Biomed Rep. 7:272–276.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Darwich L, Coma G, Peña R, Bellido R,
Blanco EJ, Este JA, Borras FE, Clotet B, Ruiz L, Rosell A, et al:
Secretion of interferon-gamma by human macrophages demonstrated at
the single-cell level after costimulation with interleukin (IL)-12
plus IL-18. Immunology. 126:386–393. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Voloshyna I, Littlefield MJ and Reiss AB:
Atherosclerosis and interferon-γ: New insights and therapeutic
targets. Trends Cardiovasc Med. 24:45–51. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gadani SP, Cronk JC, Norris GT and Kipnis
J: IL-4 in the brain: A cytokine to remember. J Immunol.
189:4213–4219. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Frodermann V, van Duijn J, van Puijvelde
GH, van Santbrink PJ, Lagraauw HM, de Vries MR, Quax PH, Bot I,
Foks AC, de Jager SC and Kuiper J: Heat-killed staphylococcus
aureus reduces atherosclerosis by inducing anti-inflammatory
macrophages. J Intern Med. 279:592–605. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yang H, Zhao P and Tian S: Clopidogrel
protects endothelium by hindering TNFα-induced VCAM-1 expression
through CaMKKβ/AMPK/Nrf2 pathway. J Diabetes Res.
2016(9128050)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rios FJ, Koga MM, Pecenin M, Ferracini M,
Gidlund M and Jancar S: Oxidized LDL induces alternative macrophage
phenotype through activation of CD36 and PAFR. Mediators Inflamm.
2013(198193)2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Badimon L, Pena E, Arderiu G, Padró T,
Slevin M, Vilahur G and Chiva-Blanch G: C-reactive protein in
atherothrombosis and angiogenesis. Front Immunol.
9(430)2018.PubMed/NCBI View Article : Google Scholar
|
